Developer of drugs based on deoxyribonucleic acid (DNA) or ribonucleic acid (RNA). The company's drugs include antisense, small interfering RNAs and delivery systems for DNA/RNA-based drugs.
Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
---|---|---|---|---|---|---|
5. Merger/Acquisition | 21-Aug-2003 | $14.1M | 00.00 | 000.00 | Completed | Clinical Trials - Phase 2 |
4. Later Stage VC | 01-Jun-2003 | 00000 | 00.00 | Completed | Clinical Trials - Phase 2 | |
3. Early Stage VC (Series B) | 01-Jun-2002 | 00.00 | 00.00 | Completed | Generating Revenue | |
2. Early Stage VC (Series A) | $1.2M | Completed | ||||
1. Seed Round | 01-Jul-1999 | $1.2M | Completed | Startup |
Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
---|---|---|---|---|---|
EPIC Ventures | Venture Capital | Minority | 000 0000 | 000000 0 | |
Pelion Venture Partners | Venture Capital | Minority | 000 0000 | 000000 0 | |
Signal Peak Ventures | Venture Capital | Minority | 000 0000 | 000000 0 |